DAWN vs NIO · rev $131.2M vs rev $12.51B
Day One Biopharmaceuticals Inc (DAWN) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
DAWN currently screens at market cap $656.8M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the DAWN and NIO stock pages for the full models.
Not investment advice.